Methods for measuring in-vivo percutaneous absorption in humans

Human and Experimental Toxicology

Volumn 27, Issue 4, 2008, Pages 289-295

  Kezic, S ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Biological monitoring; In vivo; Microdialysis; Percutaneous absorption; Spectroscopic methods; Tape stripping

Indexed keywords

HEALTH HAZARD; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; MATHEMATICAL MODEL; METABOLITE; MICRODIALYSIS; OCCUPATIONAL HEALTH; PRIORITY JOURNAL; RAMAN SPECTROMETRY; REVIEW; RISK ASSESSMENT; SKIN ABSORPTION; SPECTROPHOTOMETRY; STRATUM CORNEUM; ARTICLE; DRUG EFFECT; DRUG MONITORING; METABOLISM; METHODOLOGY; PHYSIOLOGY; SKIN; SPECTROSCOPY;

XENOBIOTIC AGENT;

DRUG MONITORING; HUMANS; MICRODIALYSIS; RISK ASSESSMENT; SKIN; SKIN ABSORPTION; SPECTRUM ANALYSIS; XENOBIOTICS;

EID: 52649177750     PISSN: 09603271     EISSN: 14770903     Source Type: Journal    
DOI: 10.1177/0960327107085825     Document Type: Review

References (66)

1. International Conference on Harmonisation. Guideline for good clinical practice, E6(R1). Accessed June 2007. 1996. p. 1-57.
2. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects, adopted by the 18th World Medical Association general assembly. Helsinki, Finland: 1964 (as amended in 2004 ).
3. http://www.ncl.ac.uk/edetox/currentposition.html
4. Akrill P Cocker J Dixon S. Dermal exposure to aqueous solutions of N-methyl pyrrolidone. Toxicol Lett 2002 ; 134: 265-269.
5. Brooke I Cocker J Delic JI Payne M Jones K Gregg NC. Dermal uptake of solvents from the vapour phase: an experimental study in humans. Ann Occup Hyg 1998 ; 42: 531-540.
6. Engstrom K Husman K Riihimaki V. Percutaneous absorption of m-xylene in man. Int Arch Occup Environ Health 1977 ; 39: 181-189.
7. Johanson G Boman A Dynésius B. Percutaneous absorption of 2-butoxyethanol in man. Scand J Work Environ Health 1988 ; 14: 101-109.
8. Johanson G Boman A. Percutaneous absorption of 2-butoxyethanol vapour in human subjects. Br J Ind Med 1991 ; 48: 788-792.
9. Kezic S Janmaat A Kruse J Monster AC Verberk MM. Percutaneous absorption of m-xylene vapour in volunteers during pre-steady and steady state. Toxicol Lett 2004 ; 153: 273-282.
10. Opdam JJ. Linear systems dynamics in toxicokinetic studies. Ann Occup Hyg 1991 ; 35: 633-649.
11. Williams FM. In vitro studies-how good are they at replacing in vivo studies for measurement of skin absorption? Environ Toxicol Pharmacol 2006 ; 21: 199-203.
12. Jakasa I Mohammadi N Krüse J Kezic S. Percutaneous absorption of neat and aqueous solutions of 2-butoxyethanol in volunteers. Int Arch Occup Environ Health 2004 ; 77: 79-84.
13. Kezic S Meuling WJ Jakasa I. Free and total urinary 2-butoxyacetic acid following dermal and inhalation exposure to 2-butoxyethanol in human volunteers. Int Arch Occup Environ Health 2004 ; 77: 580-586.
14. Kezic S Monster AC Kruse J Verberk MM. Skin absorption of some vaporous solvents in volunteers. Int Arch Occup Environ Health 2000 ; 73: 415-422.
15. Kezic S Monster AC van de Gevel IA Kruse J Opdam JJ Verberk MM. Dermal absorption of neat liquid solvents on brief exposures in volunteers. Am Ind Hyg Assoc J 2001 ; 62: 12-18.
16. Van de Sandt JJM Meuling WJA Elliott GR Cnubben NHP Hakkert BC. Comparative in vitro-in-vivo percutaneous absorption of the pesticide propoxur. Toxicol Sci 2000 ; 58: 15-22.
17. Hueber-Becker F Nohynek GJ Meuling WJ Benech-Kieffer F Toutain H. Human systemic exposure to a [14C]-para-phenylenediamine-containing oxidative hair dye and correlation with in vitro percutaneous absorption in human or pig skin. Food Chem Toxicol 2004 ; 42: 1227-1236.
18. Loizou GD Jones K Akrill P Dyne D Cocker J. Estimation of the dermal absorption of m-xylene vapor in humans using breath sampling and physiologically based pharmacokinetic analysis. Toxicol Sci 1999 ; 48: 170-179.
19. Poet TS Thrall KD Corley RA Hui X Edwards JA Weitz KK. Utility of real time breath analysis and physiologically based pharmacokinetic modeling to determine the percutaneous absorption of methyl chloroform in rats and humans. Toxicol Sci 2000 ; 54: 42-51.
20. Deutsche Forschnungsgemeinschaft (DFG). List of MAK and BAT values. Weinheim: Wiley-VCH ; 2003.
21. Health and Safety Executive (HSE). EH40/2002 occupational exposure limits 2002. London: HSE Books ; 2002.
22. De Lange EC de Boer AG Breimer DD. Methodological issues in microdialysis sampling for pharmacokinetic studies. Adv Drug Deliv Rev 2000 ; 45: 125-148.
23. Joukhadar C Muller M. Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future. Clin Pharmacokinet 2005 ; 44: 895-913.
24. Kreilgard M. Assessment of cutaneous drug delivery using microdialysis. Adv Drug Deliv Rev 2000 ; 54 (Suppl. 1): S99-S121.
25. Morgan CJ Renwick AG Friedmann PS. The role of stratum corneum and dermal microvascular perfusion in penetration and tissue levels of water-soluble drugs investigated by serum levels and tissue content in microdialysis. Br J Dermat 2003 ; 148: 434-443.
26. Schnetz E Fartasch M. Microdialysis for the evaluation of penetration through the human skin barrier-a promising tool for future research? Eur J Pharm Sci 2001 ; 12: 165-174.
27. Benfeldt E Hansen SH Volund A Menne T Shah VP. Bioequivalence of topical formulations in humans: evaluation by dermal microdialysis sampling and the dermatopharmacokinetic method. J Invest Dermatol 2007 ; 127: 170-178.
28. Benfeldt E. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects. Acta Derm Venereol Suppl 1999 ; 206: 1-59.
29. Anderson C Andersson T Boman A Molander M. Cutaneous microdialysis for the measurement in vivo of the percutaneous absorption of organic solvents. Curr Probl Dermatol 1996 ; 25: 37-46.
30. Benfeldt E Groth L. Feasibility of measuring lipophilic or protein-bound drugs in the dermis by in vivo microdialysis after topical or systemic drug administration. Acta Derm Venereol 1998 ; 78: 274-278.
31. McCleverty D Lyons R Henry B. Microdialysis sampling and the clinical determination of topical dermal bioequivalence. Int J Pharm 2006 ; 308: 1-7.
32. Chao YC Gibson RL Nylander-French LA. Dermal exposure to jet fuel (JP-8) in US Air Force personnel. Ann Occup Hyg 2005 ; 49: 639-645.
33. Dupuis D Rougier A Roguet R Lotte C Kalopissis G. In vivo relationship between layer reservoir effect and percutaneous absorption in human and rat. J Invest Dermatol 1984 ; 82: 353-356.
34. Mattorano DA Kupper LL Nylander-French LA. Estimating dermal exposure to jet fuel (naphthalene) using adhesive tape strip samples. Ann Occup Hyg 2004 ; 48: 139-146.
35. Rougier A Dupuis D Lotte C Roguet R Schaefer H. In vivo correlation between stratum corneum reservoir function and percutaneous absorption. J Invest Dermatol 1983 ; 81: 275-278.
36. Dreher F Arens A Hostynek JJ Mudumba S Ademola J Maibach HI. Colorimetric method for quantifying human Stratum corneum removed by adhesive-tape stripping. Acta Derm Venereol 1998 ; 78: 186-189.
37. Jakasa I Verberk MM Esposito M Bos JD Kezic S. Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. J Invest Dermatol 2007 ; 127: 129-134.
38. Pirot F Kalia YN Stinchcomb AL Keating G Bunge A Guy RH. Characterization of the permeability barrier of human skin in vivo. Proc Natl Acad Sci U S A 1997 ; 94: 1562-1567.
39. Tsai JC Lin CY Sheu HM Lo YL Huang YH. Noninvasive characterization of regional variation in drug transport into human stratum corneum in vivo. Pharm Res 2003 ; 20: 632-638.
40. Weigmann HJ Lindemann U Antoniou C Tsikrikas GN Stratigos AI Katsambas A. UV/VIS absorbance allows rapid, accurate, and reproducible mass determination of corneocytes removed by tape stripping. Skin Pharmacol Appl Skin Physiol 2003 ; 16: 217-227.
41. Reddy MB Stinchcomb AL Guy RH Bunge AL. Determining dermal absorption parameters in vivo from tape stripping. Pharm Res 2002 ; 19: 292-298.
42. US Food and Drug Administration (FDA). Guidance for industry. Topical dermatological drug products NDAs and ANDAs-in vivo bioavailability, bioequivalence, in vitro release and associated studies. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation ansd Research (CDER) 1998.
43. Food and Drug Cosmetics Act. 21 CFR 320.24; 2002.
44. Shah VP. IV-IVC for topically applied preparations-a critical review. Eur J Pharm Biopharm 2005 ; 60: 309-314.
45. Herkenne C; Naik A; Kalia YN; Hadgraft J; Guy RH;. Dermatopharmacokinetic prediction of topical drug bioavailability in vivo. J Invest Dermatol 2006; 127: 887-894.
46. Tsai JC Cappel MJ Weiner ND Flynn GL Ferry J. Solvent effects on the harvesting of stratum corneum from hairless mouse skin through adhesive tape stripping in vitro. Int J Pharm 1991 ; 68: 127-133.
47. Bashir SJ Chew AL Angibogu A Dreher F Maibach HI. Physical and physiological effects of stratum corneum tape stripping. Skin Res Technol 2001 ; 7: 40-48.
48. Van der Molen RG Spies F vant Noordende JM Boelsma E Mommaas AM Koerten HK. Tape stripping of human stratum corneum yields cell layers that originate from various depths because of furrows in the skin. Arch Dermatol Res 1997 ; 289: 514-518.
49. Jakasa I Verberk MM Bunge AL Kruse J Kezic S. Increased permeability for polyethylene glycols through skin compromised by sodium lauryl sulphate. Exp Dermatol 2006 ; 15: 801-807.
50. Alvarez-Roman R Naik A Kalia YN Fessi H Guy RH. Visualization of skin penetration using confocal laser scanning microscopy. Eur J Pharm Biopharm 2004 ; 58: 301-316.
51. Hanh BD Neubert RH Wartewig S Christ A Hentzsch C. Drug penetration as studied by noninvasive methods: fourier transform infrared-attenuated total reflection, fourier transform infrared, and ultraviolet photoacoustic spectroscopy. J Pharm Sci 2000 ; 89: 1106-1113.
52. Touitou E Meidan VM Horwitz E. Methods for quantitative determination of drug localized in the skin. J Control Release 198: 7-21.
53. Bommannan D Potts RO Guy RH. Examination of stratum corneum barrier function in vivo by infrared spectroscopy. J Invest Dermatol 1990 ; 95: 403-408.
54. Mak VHW Potts RO Guy RH. Percutaneous penetration enhancement in vivo measured by attenuated total reflectance infrared spectroscopy. Pharm Res 1990 ; 7: 835-841.
55. Laugel C Nascimento CD Ferrier D Marty JP Baillet A. Contribution of ATR/FT-IR spectroscopy for studying the in-vivo behavior of octylmethoxycinnamate (OMC) after topical application. Appl Spectrosc 2001 ; 55: 1173-1180.
56. Notingher I Imhof RE. Mid-infrared in vivo depth-profiling of topical chemicals on skin. Skin Res Technol 2004 ; 10: 113-121.
57. Alberti I Kalia YN Naik A Bonny J-D Guy RH. In vivo assessment of enhanced delivery of terbinafine to human stratum corneum. J Control Release 2001 ; 71: 319-327. (Pubitemid 32276051)
58. Ayala-Bravo HA Quintanar-Guerrero D Naik A Kalia YN Cornejo-Bravo JM Ganem-Quintanar A. Effects of sucrose oleate and sucrose laureate on in vivo human stratum corneum permeability. Pharm Res 2003 ; 20: 1267-1273.
59. Carden A Yost MG Fenske RA. Noninvasive method for the assessment of dermal uptake of pesticides using attenuated total reflectance infrared spectroscopy. Appl Spectrosc 2005 ; 59: 293-299.
60. Xiao P Cowen JA Imhof RE. In-vivo transdermal drug diffusion depth profiling-a newapproach to opto-thermal signal analysis. Anal Sci 2001 ; 17: S349-S352.
61. Ring A Schreiner V Wenck H Wittern KP Küpper L Keyhani R. Mid-infrared spectroscopy on skin using a silver halide fibre probe in vivo. Skin Res Technol 2006 ; 12: 18-23.
62. Caspers PJ Lucassen GW Wolthuis R Bruining HA Puppels GJ. In vitro and in vivo Raman spectroscopy of human skin. Biospectroscopy 1998 ; 4: S31-S34.
63. Caspers PJ Williams AC Carter EA Edwards HGM Barry BW Bruining HA. Automated depth-scanning confocal Raman microspectrometer for rapid in-vivo determination of water concentration profiles in human skin. J Raman Spectros 2000 ; 31: 813-818.
64. Caspers PJ Lucassen GW Carter EA Bruining HA Puppels GJ. In vivo confocal Raman microspectroscopy of the skin: noninvaisve determination of molecular concentration profiles. J Invest Dermatol 2001 ; 116: 434-442.
65. Caspers PJ Williams AC Carter EA Edwards HGM Barry BW Bruining HA. Monitoring the penetration enhancer dimethyl sulfoxide in human stratum corneum in vivo by confocal Raman spectroscopy. Pharm Res 2002 ; 31: 813-818.
66. Zhang SL Caspers PJ Puppels GJ. In vivo confocal Raman microspectroscopy of the skin: effect of skin care products on molecular concentration depth-profiles. Microsc Microanal 2001 ; 11: 790-791.